Form 4 for CRDF Cardiff Oncology, Inc.
Accepted 2023-12-19 00:00:00 ET · period of report 2023-12-19 · accession 0001628280-23-042045 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-19 | 2023-12-19 | CRDF | PACE GARY W | Dir | P - Purchase | $1.37 | +30.0K | 697.8K | +4% | +$41.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-19 | P | A | 30,000 | $1.37 | 697,761 | D | — | — |